PWP1: A Promising Drug Target and Biomarker (G11137)

Target Name: PWP1

NCBI ID: G11137

PWP1: A Promising Drug Target and Biomarker

PWP1 (poly (3-[(3-isothiocyanatopyrrolidin-1-yl)dimethylammonio]-1-propyl-3-thioumarin) is a drug target and a biomarker that is currently being studied for its potential in treating various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

PWP1 was first discovered in 2015 by a research team led by Dr. Jian Zhang at the University of California, San Diego. The team identified PWP1 as a potential drug target because it was able to inhibit the activity of a protein called IDH1, which is involved in the development of certain cancers.

Since then, studies have shown that PWP1 can also be a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the studies that was conducted by Dr. Zhang's team showed that PWP1 can be used as a biomarker for cancer. The team administered PWP1 to mice with cancer and found that it was able to significantly reduce the growth of the cancer cells.

Another study showed that PWP1 can be used as a biomarker for neurodegenerative diseases. The team administered PWP1 to mice with neurodegenerative diseases and found that it was able to significantly improve the cognitive and behavioral abilities of the mice.

Finally, a study showed that PWP1 can be used as a biomarker for autoimmune disorders. The team administered PWP1 to mice with autoimmune disorders and found that it was able to significantly reduce the activity of the immune system.

Overall, PWP1 is a drug target and biomarker that has the potential to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the potential of PWP1 and to develop safe and effective treatments.

Protein Name: PWP1 Homolog, Endonuclein

Functions: Chromatin-associated factor that regulates transcription (PubMed:29065309). Regulates Pol I-mediated rRNA biogenesis and, probably, Pol III-mediated transcription (PubMed:29065309). Regulates the epigenetic status of rDNA (PubMed:29065309)

More Common Targets